Lilly Pharmaceuticals: Our company's treatment for lymphocytic leukemia, Jaypirca, has been approved by the FDA
芊芊551
发表于 2023-12-2 09:57:12
213
0
0
Lilly Pharmaceuticals claims that its treatment for lymphocytic leukemia, Jaypirca (pirobrutinib/pirobrutinib), has been approved by the US Food and Drug Administration (FDA).
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
